Business Context and Reporting Period
This Form 6-K filing by Compugen Ltd. covers the month of November 2004, specifically dated November 8, 2004. The registrant is a genomics-based drug and diagnostic discovery company headquartered in Tel-Aviv, Israel, which utilizes mathematics, computer science, and physics to advance biological understanding and product discovery.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to announce a corporate event and does not contain financial statements or quantitative performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing incorporates by reference a press release regarding an upcoming investor presentation.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Martin Gerstel, Chairman of the Board, is scheduled to present at the New York Society of Security Analysts' 8th Annual Healthcare Industry Conference on November 17, 2004, at 9:10 AM Eastern Time.
- Access: A live webcast and a one-year replay of the presentation will be available on the company's investor website.
- Business Overview: The company maintains an early-stage in-house pipeline of therapeutic protein candidates and has out-licensed additional discoveries. Key partners include Abbott Laboratories, Novartis, and Pfizer.
- Subsidiaries: The company operates Keddem Bioscience (small-molecule drug discovery) and Evogene (agricultural biotechnology).
Key Facts for Investor Verification
- Verify the date and time of the upcoming presentation by Chairman Martin Gerstel on November 17, 2004.
- Confirm the availability of the live webcast and replay via the official Compugen investor relations website.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F for financial performance.
- Review the status of the in-house pipeline and out-licensed discoveries mentioned in the company overview.